FluoGuide A/S Feed

	Est. tid*
2025-11-27	07:10	Kvartalsrapport 2025-Q3
2025-08-28	07:10	Kvartalsrapport 2025-Q2
2025-05-28	-	Kvartalsrapport 2025-Q1
2025-03-28	-	X-dag ordinarie utdelning FLUO 0.00 DKK
2025-03-27	-	Årsstämma
2025-02-27	-	Bokslutskommuniké 2024
2024-11-27	-	Kvartalsrapport 2024-Q3
2024-08-29	-	Kvartalsrapport 2024-Q2
2024-05-30	-	Kvartalsrapport 2024-Q1
2024-03-21	-	X-dag ordinarie utdelning FLUO 0.00 DKK
2024-03-20	-	Årsstämma
2024-02-28	-	Bokslutskommuniké 2023
2023-11-29	-	Kvartalsrapport 2023-Q3
2023-08-30	-	Kvartalsrapport 2023-Q2
2023-05-31	-	Kvartalsrapport 2023-Q1
2023-03-22	-	X-dag ordinarie utdelning FLUO 0.00 DKK
2023-03-21	-	Årsstämma
2023-02-28	-	Bokslutskommuniké 2022
2022-11-24	-	Kvartalsrapport 2022-Q3
2022-08-25	-	Kvartalsrapport 2022-Q2
2022-05-31	-	Kvartalsrapport 2022-Q1
2022-05-19	-	X-dag ordinarie utdelning FLUO 0.00 DKK
2022-05-18	-	Årsstämma
2022-03-30	-	Bokslutskommuniké 2021
2021-11-24	-	Kvartalsrapport 2021-Q3
2021-08-25	-	Kvartalsrapport 2021-Q2
2021-05-26	-	Kvartalsrapport 2021-Q1
2021-05-03	-	X-dag ordinarie utdelning FLUO 0.00 DKK
2021-02-26	-	Bokslutskommuniké 2020
2021-02-09	-	Årsstämma
2020-11-20	-	Kvartalsrapport 2020-Q3
2020-08-14	-	Kvartalsrapport 2020-Q2
2020-05-27	-	Kvartalsrapport 2020-Q1
2020-04-09	-	X-dag ordinarie utdelning FLUO 0.00 DKK
2020-04-08	-	Årsstämma
2020-02-28	-	Bokslutskommuniké 2019
2019-11-29	-	Kvartalsrapport 2019-Q3
2019-05-31	-	Kvartalsrapport 2019-Q1

Land	Danmark
Lista	First North Stockholm
Sektor	Hälsovård
Industri	Medicinteknik

2025-06-10 09:02:00 FG001 clinical data in High-Grade Glioma is now published in Neurosurgery 40,90 DKK | +2,76%

2025-05-28 07:06:00 FluoGuide A/S publishes interim report for the period January – March 2025 - On track - first patients enrolled in CT-005 41,90 DKK | -2,78%

2025-04-15 10:28:00 FluoGuide includes first patient in phase II trial of FG001 for head and neck cancer 38,80 DKK | -0,26%

2025-03-27 15:50:00 Minutes from Annual General Meeting in FluoGuide A/S 38,00 DKK | -2,69%

2025-03-12 09:49:00 Notice of Annual General Meeting in FluoGuide A/S 41,10 DKK | +5,38%

2025-02-27 07:03:00 FluoGuide A/S publishes year-end and annual report for the fiscal year 2024 43,80 DKK | -4,37%

2025-02-27 07:00:00 FluoGuide A/S publishes interim report for the period January – December 2024 43,80 DKK | -4,37%

2025-01-15 16:34:00 FluoGuide A/S receives approval for phase II trial in head and neck cancer 45,10 DKK | +1,01%

2024-11-27 07:00:00 FluoGuide A/S publishes interim report for the period January – September 2024 36,90 DKK | +2,93%

2024-11-19 13:43:00 Publication of positive phase II clinical data for FG001 in patients with head and neck cancer 35,85 DKK | +4,52%

2024-11-12 18:23:00 FluoGuide A/S issue warrants to board member, CMO and CFO 33,90 DKK | -0,44%

2024-10-21 16:13:00 Roger Gunnarsson resigns as board member due to return to a full-time investment banking career, which precludes him from holding board position in FluoGuide 39,25 DKK | +2,35%

2024-10-07 13:13:00 FluoGuide A/S submits Clinical Trial Application for phase II trial in head and neck cancer 41,00 DKK | +0,37%

2024-08-29 08:55:00 FluoGuide A/S publishes interim report for the period January – June 2024 41,00 DKK | -1,20%

2024-08-26 09:05:00 FluoGuide appoints Jens Ellrich as Chief Medical Officer 41,35 DKK | +1,97%

2024-06-18 23:12:00 FluoGuide has completed a directed share issue to existing and new investors raising proceeds of SEK 60 million 46,80 DKK | +1,85%

2024-06-18 17:31:00 FluoGuide intends to carry out a directed share issue of approximately SEK 60 million 46,80 DKK | +1,85%

2024-05-30 08:51:00 FluoGuide A/S publishes interim report for the period January – March 2024 46,90 DKK | -1,26%

2024-05-27 09:40:00 FluoGuide selects laser system for photothermal cancer therapy with FG001 49,25 DKK | +1,23%

2024-03-20 14:25:00 Minutes from Annual General Meeting in FluoGuide A/S 51,00 DKK | -5,20%

2024-03-13 11:17:00 Chief Financial Officer (CFO) Ole Larsen buys shares 56,00 DKK | +3,32%

2024-03-12 12:12:00 FluoGuide enters collaboration within robot assisted head and neck cancer surgery with Intuitive Surgical, a world leading robotic-assisted surgery company 54,20 DKK | +12,68%

2024-03-01 12:41:00 Notice of Annual General Meeting in FluoGuide A/S 53,40 DKK | -2,55%

2024-02-28 08:10:00 FluoGuide A/S publishes year-end and annual report for the fiscal year 2023 54,20 DKK | -5,24%

2024-02-23 16:02:00 FluoGuide A/S issues warrants to CFO 56,00 DKK | +6,06%

2024-01-08 11:33:00 FluoGuide provides strategic update and outlines development plans towards commercialization of FG001 73,00 DKK | 0,00%

2023-12-09 16:17:00 Chief Development Officer (CDO) Grethe Nørskov Rasmussen sells shares 64,60 SEK | -6,38%

2023-12-08 09:55:00 FluoGuide raises SEK 12 million through exercise of warrants 69,00 DKK | +0,58%

2023-11-29 08:00:00 FluoGuide A/S publishes interim report for the period January – September 2023 66,40 DKK | -3,77%

2023-11-13 08:35:00 FluoGuide announces FG001 meets primary endpoint in phase llb trial in aggressive brain cancer 85,20 DKK | +0,24%

2023-11-06 10:01:00 FluoGuide confirms positive topline results from phase lla trial of FG001 in head & neck cancer at International Academy of Oral Oncology conference 88,00 DKK | +0,92%

2023-10-03 10:34:00 FluoGuide receives FDA Orphan Drug Designation for FG001 in high-grade glioma 88,60 DKK | +5,73%

2023-09-08 12:00:00 FluoGuide receives Danish award for the best share price performance since IPO 92,00 DKK | -0,22%

2023-09-07 14:32:00 Positive interim data from phase lla trial of FG001 in head & neck cancer presented as a case report at the World Molecular Imaging Congress in Prague 92,20 DKK | +4,77%

2023-08-30 08:05:00 FluoGuide A/S publishes interim report for the period January – June 2023 93,00 DKK | +1,09%

2023-08-29 09:32:00 FluoGuide reports further positive interim data from phase IIa trial of FG001 in head & neck cancer 92,00 DKK | +6,73%

2023-08-28 16:15:00 FluoGuide completes patient enrollment and treatment in FG001 phase llb clinical trial in aggressive brain cancer 86,20 DKK | -2,93%

2023-08-28 12:53:00 FluoGuide A/S issues warrants to the investors participating in the directed share issue 86,20 DKK | -2,93%

2023-07-31 18:42:00 FluoGuide A/S issues warrants to Board members, management and employees 79,00 DKK | -1,00%

2023-07-25 16:12:00 Minutes from Extraordinary General Meeting in FluoGuide A/S 77,40 DKK | -2,76%

2023-07-07 13:35:00 FluoGuide convenes an extraordinary general meeting 82,00 DKK | +0,24%

2023-07-05 13:33:00 FluoGuide completes a Directed Share Issue raising SEK 15 million 81,20 DKK | -1,93%

2023-06-20 08:18:00 FluoGuide announces positive interim results from phase IIa trial of FG001 in head & neck cancer 86,20 DKK | +5,12%

2023-06-07 09:00:00 FluoGuide announces positive topline results from phase IIa trial of FG001 in lung cancer 89,40 DKK | +4,93%

2023-05-31 08:20:00 FluoGuide A/S publishes interim report for the period January – March 2023 84,80 DKK | -1,40%

2023-05-24 09:52:00 FluoGuide provides update on strong clinical trial progress 86,00 DKK | +0,94%

2023-03-21 12:04:00 FluoGuide awarded prestigious grant together with two academic partners 101,00 DKK | +1,00%

2023-03-21 11:47:00 Minutes from Annual General Meeting in FluoGuide A/S 101,00 DKK | +1,00%

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

FluoGuide A/S

Prenumeration

Kalender

Beskrivning

FluoGuide A/S

Prenumeration

Kalender

Beskrivning

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden